Cargando…

Cancer: A disease at the crossroads of trade‐offs

Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacqueline, Camille, Biro, Peter A., Beckmann, Christa, Moller, Anders Pape, Renaud, François, Sorci, Gabriele, Tasiemski, Aurélie, Ujvari, Beata, Thomas, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322410/
https://www.ncbi.nlm.nih.gov/pubmed/28250806
http://dx.doi.org/10.1111/eva.12444
_version_ 1782509841699307520
author Jacqueline, Camille
Biro, Peter A.
Beckmann, Christa
Moller, Anders Pape
Renaud, François
Sorci, Gabriele
Tasiemski, Aurélie
Ujvari, Beata
Thomas, Frédéric
author_facet Jacqueline, Camille
Biro, Peter A.
Beckmann, Christa
Moller, Anders Pape
Renaud, François
Sorci, Gabriele
Tasiemski, Aurélie
Ujvari, Beata
Thomas, Frédéric
author_sort Jacqueline, Camille
collection PubMed
description Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natural selection, are governed by trade‐offs such as between survival and proliferation. Second, selection might also have shaped trade‐offs at the organismal level, especially regarding protective mechanisms against cancer. Cancer can also emerge as a consequence of additional trade‐offs in organisms (e.g., eco‐immunological trade‐offs). Here, we review the wide range of trade‐offs that occur at different scales and their relevance for understanding cancer dynamics. We also discuss how acknowledging these phenomena, in light of human evolutionary history, may suggest new guidelines for preventive and therapeutic strategies.
format Online
Article
Text
id pubmed-5322410
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53224102017-03-01 Cancer: A disease at the crossroads of trade‐offs Jacqueline, Camille Biro, Peter A. Beckmann, Christa Moller, Anders Pape Renaud, François Sorci, Gabriele Tasiemski, Aurélie Ujvari, Beata Thomas, Frédéric Evol Appl Reviews and Syntheses Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natural selection, are governed by trade‐offs such as between survival and proliferation. Second, selection might also have shaped trade‐offs at the organismal level, especially regarding protective mechanisms against cancer. Cancer can also emerge as a consequence of additional trade‐offs in organisms (e.g., eco‐immunological trade‐offs). Here, we review the wide range of trade‐offs that occur at different scales and their relevance for understanding cancer dynamics. We also discuss how acknowledging these phenomena, in light of human evolutionary history, may suggest new guidelines for preventive and therapeutic strategies. John Wiley and Sons Inc. 2016-12-26 /pmc/articles/PMC5322410/ /pubmed/28250806 http://dx.doi.org/10.1111/eva.12444 Text en © 2016 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews and Syntheses
Jacqueline, Camille
Biro, Peter A.
Beckmann, Christa
Moller, Anders Pape
Renaud, François
Sorci, Gabriele
Tasiemski, Aurélie
Ujvari, Beata
Thomas, Frédéric
Cancer: A disease at the crossroads of trade‐offs
title Cancer: A disease at the crossroads of trade‐offs
title_full Cancer: A disease at the crossroads of trade‐offs
title_fullStr Cancer: A disease at the crossroads of trade‐offs
title_full_unstemmed Cancer: A disease at the crossroads of trade‐offs
title_short Cancer: A disease at the crossroads of trade‐offs
title_sort cancer: a disease at the crossroads of trade‐offs
topic Reviews and Syntheses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322410/
https://www.ncbi.nlm.nih.gov/pubmed/28250806
http://dx.doi.org/10.1111/eva.12444
work_keys_str_mv AT jacquelinecamille canceradiseaseatthecrossroadsoftradeoffs
AT biropetera canceradiseaseatthecrossroadsoftradeoffs
AT beckmannchrista canceradiseaseatthecrossroadsoftradeoffs
AT molleranderspape canceradiseaseatthecrossroadsoftradeoffs
AT renaudfrancois canceradiseaseatthecrossroadsoftradeoffs
AT sorcigabriele canceradiseaseatthecrossroadsoftradeoffs
AT tasiemskiaurelie canceradiseaseatthecrossroadsoftradeoffs
AT ujvaribeata canceradiseaseatthecrossroadsoftradeoffs
AT thomasfrederic canceradiseaseatthecrossroadsoftradeoffs